Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
WGS
#1574
GeneDx Holdings Corp. Class A Common Stock
79.7
1
+0.35%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.35%
Aylık değişim
-16.98%
6 aylık değişim
-37.42%
Yıllık değişim
-21.08%
Önceki kapanış
79.4
3
Open
79.7
1
Bid
Ask
Low
79.7
1
High
79.7
1
Hacim
69
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
WGS
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
1.34 M
7.42 M
11.77 M
26.05 M
28.07 M
29.29 M
—
Valuation ratios
Enterprise value
—
—
—
-30.9 M
2.07 B
3.7 B
11.73 B
Price to earnings ratio
—
—
—
-0.37
-39.62
-178.16
2 056.29
Price to sales ratio
—
—
—
0.32
6.77
8.71
30.64
Price to cash flow ratio
—
—
—
-0.36
-72.53
111.94
-532.38
Price to book ratio
—
—
—
0.28
8.43
12.09
20.21
Enterprise value to EBITDA ratio
—
—
—
0.19
-135.39
3 125.99
3 265.68
Profitability ratios
Return on assets %
—
0.44
1.12
0.42
0.12
0.04
0.05
Return on equity %
—
0.63
2.16
0.77
0.21
0.07
0.08
Return on invested capital %
—
648.97
1 177.56
226.39
36.94
18.96
21.28
Gross margin %
—
7.82
11.4
44.19
63.64
69.74
278.22
Operating margin %
—
210.25
284.48
88.67
7.6
3.06
13.69
EBITDA margin %
—
-197.31
-269.16
-78.25
-5.01
0.28
-6.97
Net margin %
—
115.64
233.91
86.3
17.12
4.92
21.29
Liquidity ratios
Quick ratio
—
4.44
1.38
2.95
3.42
2.34
10.69
Current ratio
14.12
4.77
1.47
3.1
3.61
2.46
11.29
Inventory turnover
—
6.84
11.1
10.03
11.43
10.52
10.9
Asset turnover
—
0.43
0.45
0.45
0.73
0.91
0.91
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.02
0.01
0.13
0.12
0.09
0.42
Long term debt to total equity ratio
—
0.03
0.02
0.23
0.21
0.16
0.72
Per share metrics
Operating cash flow per share
—
58.15
31.18
7.41
1.06
1.16
1.15
EBIT per share
—
-134.5
-67.5
-7.37
-0.86
-0.29
-0.68
EBITDA per share
—
-127.84
-61.71
-6.56
-0.57
0.04
-0.35
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
122.32
12.1
5.35
5.25
5.98
21.54
Net current asset value per share
—
147.64
20.77
7.5
7.36
9.37
32.52
Tangible book value per share
—
118.5
6.55
2.28
3.22
4.41
14.69
Working capital per share
—
116.72
6.67
5.08
5.32
5.56
20.81
Book value per share
—
118.5
24.78
9.38
9.12
10.76
39.37
Haberler
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS)
These Analysts Slash Their Forecasts On GeneDx After Q4 Results - GeneDx Holdings (NASDAQ:WGS)
BTIG, GeneDx için hedef fiyatı düşürdü
BTIG cuts GeneDx stock price target on back-end loaded growth outlook
GeneDx Holdings Corp. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:WGS) 2026-02-23
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx 4Ç 2025 sunumu: %54 gelir artışı, agresif 2026 planı
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion
Canaccord Genuity, GeneDx hissesi için Al tavsiyesini tekrarladı, 170 dolar hedefi korudu
GeneDx hissesi sonuç çağrısı öncesi TD Cowen tarafından Al önerisinde tutuldu
GeneDx stock maintained at Buy by TD Cowen ahead of results call
Canaccord Genuity reiterates Buy on GeneDx stock, keeps $170 target